AGWCA
CNMD icon

Annis Gardner Whiting Capital Advisors’s CONMED CNMD Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18
Closed -$847 – 1237
2025
Q3 		$847 Sell
18
-129
-88% -$6.69K ﹤0.01% 1012
2025
Q2 		$7.66K Buy
+147
New +$8.07K ﹤0.01% 781

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's CNMD Position: Q4 2025 in Review

Annis Gardner Whiting Capital Advisors sold out of CONMED (CNMD) in Q4 2025, closing a stake of 18 shares — an estimated $847 sold.

Annis Gardner Whiting Capital Advisors first reported a position in CNMD in Q2 2025 and held it in 2 quarters. The position peaked at $7.66K in Q2 2025. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2025.

  • Annis Gardner Whiting Capital Advisors reported no remaining CONMED position as of Q4 2025 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 18 CONMED shares in Q4 2025, an estimated $847.
  • Annis Gardner Whiting Capital Advisors first reported a position in CONMED in Q2 2025 and held it in 2 quarters.
  • Annis Gardner Whiting Capital Advisors's CONMED position peaked at $7.66K in Q2 2025.
  • 265 funds tracked by Wall St. Rank held CONMED as of Q4 2025.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q4 2025, filed 9 Feb 2026.